Molecular Templates Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.5600
- Today's High:
- $0.6700
- Open Price:
- $0.6600
- 52W Low:
- $0.56
- 52W High:
- $5.9
- Prev. Close:
- $0.6436
- Volume:
- 119712
Company Statistics
- Market Cap.:
- $0.033 billion
- Book Value:
- 0.462
- Revenue TTM:
- $0.033 billion
- Operating Margin TTM:
- -247.8%
- Gross Profit TTM:
- $-0.046 billion
- Gross Profit TTM:
- $-0.046 billion
- Profit Margin:
- -260.7%
- Return on Assets TTM:
- -26.7%
- Return on Equity TTM:
- -140.4%
Company Profile
Molecular Templates Inc had its IPO on 2005-02-04 under the ticker symbol MTEM.
The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Molecular Templates Inc has a staff strength of 0 employees.
Stock update
Shares of Molecular Templates Inc opened at $0.66 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $0.56 - $0.67, and closed at $0.59.
This is a -8.9% slip from the previous day's closing price.
A total volume of 119,712 shares were traded at the close of the day’s session.
In the last one week, shares of Molecular Templates Inc have slipped by -41.37%.
Molecular Templates Inc's Key Ratios
Molecular Templates Inc has a market cap of $0.033 billion, indicating a price to book ratio of 1.363 and a price to sales ratio of 0.994.
In the last 12-months Molecular Templates Inc’s revenue was $0.033 billion with a gross profit of $-0.046 billion and an EBITDA of $-0.075 billion. The EBITDA ratio measures Molecular Templates Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Molecular Templates Inc’s operating margin was -247.8% while its return on assets stood at -26.7% with a return of equity of -140.4%.
In Q2, Molecular Templates Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 70.8%.
Molecular Templates Inc’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-1.384 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Molecular Templates Inc’s profitability.
Molecular Templates Inc stock is trading at a EV to sales ratio of 0.0087 and a EV to EBITDA ratio of 0.297. Its price to sales ratio in the trailing 12-months stood at 0.994.
Molecular Templates Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Molecular Templates Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Molecular Templates Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Molecular Templates Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Molecular Templates Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Molecular Templates Inc paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $0.59
- 52-Week High
- $5.9
- 52-Week Low
- $0.56
- Analyst Target Price
- $8.33
Molecular Templates Inc stock is currently trading at $0.59 per share. It touched a 52-week high of $5.9 and a 52-week low of $5.9. Analysts tracking the stock have a 12-month average target price of $8.33.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Molecular Templates Inc
Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)
Most Active
Top Gainers
Top Losers
About
Molecular Templates, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of biological therapies for the treatment of cancer and other diseases. The company is headquartered in Austin, Texas.